Given the fundamental role TGF-β plays in metastasis, our findings could potentially be extended to additional invasive cancers such as other breast cancer subtypes, gliomas, and melanomas as intact SMAD signaling machinery is present in most of these cancer types 3. This evidence concerns the gene TGFB1 and breast cancer.